International Biotechnology (LON:IBT) Stock Price Passes Above 200-Day Moving Average of $657.46

International Biotechnology (LON:IBTGet Free Report)’s share price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 657.46 ($8.79) and traded as high as GBX 682 ($9.12). International Biotechnology shares last traded at GBX 676 ($9.04), with a volume of 31,526 shares changing hands.

International Biotechnology Trading Up 0.6 %

The firm has a market cap of £249.85 million, a PE ratio of 1,408.33 and a beta of 0.21. The company has a debt-to-equity ratio of 9.66, a current ratio of 0.46 and a quick ratio of 0.32. The business has a 50-day moving average price of GBX 682.25 and a two-hundred day moving average price of GBX 657.46.

International Biotechnology Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, August 23rd. Shareholders of record on Thursday, July 25th were issued a dividend of GBX 14.50 ($0.19) per share. This is an increase from International Biotechnology’s previous dividend of $13.90. This represents a yield of 2.28%. The ex-dividend date of this dividend was Thursday, July 25th. International Biotechnology’s dividend payout ratio (DPR) is 6,041.67%.

Insiders Place Their Bets

In other International Biotechnology news, insider Gillian Elcock purchased 1,407 shares of the stock in a transaction dated Wednesday, July 24th. The shares were acquired at an average cost of GBX 709 ($9.48) per share, for a total transaction of £9,975.63 ($13,343.54). 4.18% of the stock is currently owned by company insiders.

About International Biotechnology

(Get Free Report)

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.

Featured Stories

Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.